Cardiac Rehabilitation for TIA Patients (CR-TIA)
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine, in patients following a TIA, whether a 6-month case-managed exercise based multi-factorial cardiac rehabilitation program (CR), similar to those used in patients following a heart attack, can significantly improve exercise capacity, reduce cholesterol, reduce depression, and improve thinking ability.
| Condition | Intervention | Phase |
|---|---|---|
|
TIA (Transient Ischemic Attack) |
Behavioral: Comprehensive Cardiac Rehabilitation (CR) |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Comprehensive Cardiac Rehabilitation Programming For Patients Following Transient Ischemic Attack |
- To determine compared to usual care, whether a 6-month CR strategy results in significant improvements of functional capacity, lipid profile, depression symptoms and cognition. [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
- Outcomes include cerebrovascular and cardiovascular events, pre-post changes in physiological, anthropometric and behavioral vascular risk factors, neurocognitive measures, and quality of life. [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 200 |
| Study Start Date: | September 2007 |
| Estimated Study Completion Date: | March 2012 |
| Estimated Primary Completion Date: | March 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: 0
Usual Care as provided through the Stroke Prevention Clinic
|
|
|
Active Comparator: 1
Usual Care plus Comprehensive Cardiac Rehabilitation Program
|
Behavioral: Comprehensive Cardiac Rehabilitation (CR)
6-month Comprehensive Cardiac Rehabilitation program consisting of: 1) initial medical assessment by case manager and physician to determine CR strategies; 2) entry exercise stress test; 3) multi-disciplinary assessment and intervention to achieve risk factor targets in nutrition & psychological services as needed; 4) twice per week supervised exercise training and twice per week home-based exercise following an individualized, progressive prescription; 5) Exit assessment at 6 months.
|
Detailed Description:
Similar risk factors predispose patients to both cardiovascular and cerebrovascular events. Two hundred consecutive patients from Stroke Prevention Clinics (SPC) at London Health Sciences Centre and the Ottawa Hospital (100 patients from each site) who have sustained a Transient Ischemic Attack (TIA) or mild non-disabling stroke will participate in a randomized controlled trial in which they will either receive Usual Care (UC) as delivered by the SPC, or enter the existing multi-disciplinary 6-month comprehensive cardiac rehabilitation (CR) intervention at LHSC and Ottawa in addition to receiving UC. This study seeks to determine the benefits of providing a CR program to TIA/mild non-disabling stroke patients.
Eligibility| Ages Eligible for Study: | 20 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Documented TIA or mild non-disabling stroke within the previous 3 months.
- At least one of the following vascular risk factors: hypertension, ischemic heart disease, diabetes mellitus, dyslipidemia or cigarette smoking
Exclusion Criteria:
- Inability to speak or understand English or provide informed consent.
- Severe aphasia that renders communication difficult or impossible.
- Modified Rankin Scale score of greater than or equal to 3.
- Mini-Mental Status Examination score of less than or equal to 20.
- Evidence of intracranial hemorrhage confirmed by CT scan or MRI study.
- Anticipated or recent (<30 days) carotid endarterectomy, angioplasty and/or stenting.
- Resides >1 hour travel time from London or Ottawa.
- Prior participation in a CCR program.
- Inability to perform expected exercise training of CCR program.
- Evidence of cardioembolic source for TIA/stroke such as atrial fibrillation, valvular disease, septal defect or left ventricular wall motion abnormality.
- Participation in another clinical trial that could interfere with the intervention or outcomes of the current study.
Contacts and Locations| Contact: Rosanna Turner, B.A. | 519-685-8500 ext 36570 | rosanna.turner@lhsc.on.ca |
| Contact: Neville Suskin, MBChB MSc | 519-663-3488 | neville.suskin@lhsc.on.ca |
| Canada, Ontario | |
| London Health Sciences Centre | Recruiting |
| London, Ontario, Canada, N6A 5A5 | |
| Contact: Rosanna Turner, BA 519-685-8500 ext 36570 rosanna.turner@lhsc.on.ca | |
| Principal Investigator: Neville G. Suskin, MBChB, MSc | |
| University of Ottawa Heart Institute | Recruiting |
| Ottawa, Ontario, Canada, K1Y 4W7 | |
| Contact: Tania Bennett, BSc 613-798-5555 ext 19275 tbennett@ottawaheart.ca | |
| Contact: Robert Reid, PhD, MBA 613-761-5058 breid@ottawaheart.ca | |
| Sub-Investigator: Robert Reid, PhD, MBA | |
| Principal Investigator: | Neville G. Suskin, MBChB, MSc | University of Western Ontario & London Health Sciences Centre |
More Information
No publications provided
| Responsible Party: | Dr. Neville Suskin, Lawson Health Research Institute |
| ClinicalTrials.gov Identifier: | NCT00536562 History of Changes |
| Other Study ID Numbers: | R-07-251 |
| Study First Received: | September 27, 2007 |
| Last Updated: | December 13, 2010 |
| Health Authority: | Canada: Ethics Review Committee |
Keywords provided by Lawson Health Research Institute:
|
Comprehensive Cardiac Rehabilitation Randomized Controlled Trial TIA (Transient Ischemic Attack) Mild Non-Disabling Stroke Vascular Protection |
Additional relevant MeSH terms:
|
Ischemic Attack, Transient Ischemia Brain Ischemia Cerebrovascular Disorders Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Vascular Diseases Cardiovascular Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 23, 2013